Gary E. Archer

Best Publications

• Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma

  John H. Sampson;Amy B Heimberger;Gary E. Archer;Kenneth D. Aldape

  912
  Citations

• Increased regulatory T-cell fraction amidst a diminished CD4 compartment explains cellular immune defects in patients with malignant glioma.

  Peter E. Fecci;Duane A. Mitchell;John F. Whitesides;Weihua Xie

  676
  Citations

• Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients

  Duane A. Mitchell;Kristen A. Batich;Michael D. Gunn;Min-Nung Huang

  572
  Citations

• Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma.

  Peter A. Humphrey;Albert J. Wong;Bert Vogelstein;Michael R. Zalutsky

  464
  Citations

• Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function.

  Peter E. Fecci;Hidenobu Ochiai;Duane A. Mitchell;Peter M. Grossi

  388
  Citations

• Progress Report of a Phase I Study of the Intracerebral Microinfusion of a Recombinant Chimeric Protein Composed of Transforming Growth Factor (TGF)-α and a Mutated form of the Pseudomonas Exotoxin Termed PE-38 (TP-38) for the Treatment of Malignant Brain Tumors

  John H. Sampson;Gamal Akabani;Gary E. Archer;Darell D. Bigner

  363
  Citations

• Mutant Epidermal Growth Factor Receptor Up-Regulates Molecular Effectors of Tumor Invasion

  Anita Lal;Chad A. Glazer;Holly M. Martinson;Henry S. Friedman

  359
  Citations

• An epidermal growth factor receptor variant III-targeted vaccine is safe and immunogenic in patients with glioblastoma multiforme.

  John H. Sampson;Gary E. Archer;Duane A. Mitchell;Amy B. Heimberger

  334
  Citations

• Long-term Survival in Glioblastoma with Cytomegalovirus pp65-Targeted Vaccination

  Kristen A. Batich;Elizabeth A. Reap;Gary E. Archer;Luis Sanchez-Perez

  301
  Citations

• Subcutaneous vaccination with irradiated, cytokine-producing tumor cells stimulates CD8+ cell-mediated immunity against tumors located in the "immunologically privileged" central nervous system

  John H. Sampson;Gerald E. Archer;David M. Ashley;Herbert E. Fuchs

  300
  Citations

• Epidermal growth factor receptor VIII peptide vaccination is efficacious against established intracerebral tumors.

  Amy B. Heimberger;Laura E. Crotty;Gary E. Archer;Kenneth R. Hess

  288
  Citations

• The class III variant of the epidermal growth factor receptor (EGFRvIII): characterization and utilization as an immunotherapeutic target

  C J Wikstrand;C J Reist;G E Archer;M R Zalutsky

  253
  Citations

• Unarmed, tumor-specific monoclonal antibody effectively treats brain tumors.

  John H. Sampson;Laura E. Crotty;Samson Lee;Gary E. Archer

  253
  Citations

• Brain Tumors in Mice Are Susceptible to Blockade of Epidermal Growth Factor Receptor (EGFR) with the Oral, Specific, EGFR-Tyrosine Kinase Inhibitor ZD1839 (Iressa)

  Amy B. Heimberger;Chris A. Learn;Gary E. Archer;Roger E. McLendon

  240
  Citations

• Tumor-specific immunotherapy targeting the EGFRvIII mutation in patients with malignant glioma

  John H. Sampson;Gary E. Archer;Duane A. Mitchell;Amy B. Heimberger

  213
  Citations

• Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant III contributes to the neoplastic phenotype of glioblastoma multiforme.

  Chris A. Learn;Tristan L. Hartzell;Carol J. Wikstrand;Gary E. Archer

  201
  Citations

• Systemic administration of a bispecific antibody targeting EGFRvIII successfully treats intracerebral glioma

  Bryan D. Choi;Chien-Tsun Kuan;Mingqing Cai;Gary E. Archer

  173
  Citations

• EGFRvIII-Targeted Vaccination Therapy of Malignant Glioma

  Bryan D. Choi;Gary E. Archer;Duane A. Mitchell;Amy B. Heimberger

  167
  Citations

• A Novel Inhibitor of Signal Transducers And Activators Of Transcription 3 Activation Is Efficacious Against Established Central Nervous System Melanoma and Inhibits Regulatory T Cells

  Ling Yuan Kong;Mohamed K. Abou-Ghazal;Jun Wei;Arup Chakraborty

  166
  Citations

• Tumor-specific Anti-Epidermal Growth Factor Receptor Variant III Monoclonal Antibodies: Use of the Tyramine-Cellobiose Radioiodination Method Enhances Cellular Retention and Uptake in Tumor Xenografts

  Craig J. Reist;Gary E. Archer;Shekar N. Kurpad;Carol J. Wikstrand

  163
  Citations